| PANOVSKÁ, Anna, Yvona BRYCHTOVÁ, Gabriela VAŇKOVÁ, Boris TICHÝ, Šárka POSPÍŠILOVÁ, Jiří MAYER a Michael DOUBEK. Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment. In 16th Congress of the European Hematology Association in Haematologica - the hematology journal. 2011. ISSN 0390-6078. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{960241,
author = {Panovská, Anna and Brychtová, Yvona and Vaňková, Gabriela and Tichý, Boris and Pospíšilová, Šárka and Mayer, Jiří and Doubek, Michael},
booktitle = {16th Congress of the European Hematology Association in Haematologica - the hematology journal},
language = {eng},
title = {Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment.},
year = {2011}
}
TY - CONF
ID - 960241
AU - Panovská, Anna - Brychtová, Yvona - Vaňková, Gabriela - Tichý, Boris - Pospíšilová, Šárka - Mayer, Jiří - Doubek, Michael
PY - 2011
TI - Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment.
ER -
PANOVSKÁ, Anna, Yvona BRYCHTOVÁ, Gabriela VAŇKOVÁ, Boris TICHÝ, Šárka POSPÍŠILOVÁ, Jiří MAYER a Michael DOUBEK. Prognosis of relapsed chronic lymphocytic leukemia (CLL) after combined fludarabine, cyclophosphamide and rituximab (FCR) treatment. In \textit{16th Congress of the European Hematology Association in Haematologica - the hematology journal}. 2011. ISSN~0390-6078.
|
